Long Noncoding RNA BLACAT1 is Overexpressed in Hepatocellular Carcinoma and Its Downregulation Suppressed Cancer Cell Development Through Endogenously Competing Against Hsa-miR-485-5p
Overview
General Medicine
Pharmacology
Authors
Affiliations
Objective: In this work, we explored the expression and mechanistic role of long noncoding RNA (lncRNA), bladder cancer associated transcript 1 (BLACAT1) in human hepatocellular carcinoma (HCC).
Methods: BLACAT1 expression in bothin vitro HCC cell lines and in vivo human HCC clinical samples were assessed by qRT-PCR. In HeG2 and MHCC97 L cells, BLACAT1 downregulation was induced by lentiviral infection to evaluate its functions in regulating HCC cancer cell proliferation and invasion in vitro, and xenograft in vivo. A BLACAT1 endogenously competing candidate, human microRNA-485-5p (has-miR-485-5p) was assessed in dual-luciferase assay and qRT-PCR in HCC cells. Furthermore, has-miR-485-5p was inhibited in BLACAT1-downregulated HeG2 and MHCC97 L cells to evaluate the correlation of has-miR-485-5p in BLACAT1-associated functional regulation in HCC cells.
Results: BLACAT1was found to be overexpressed in both HCC cells and human HCC tumors. In HeG2 and MHCC97 L cells, lentivirus-induced BLACAT1 downregulation inhibited cancer cellin vitro proliferation and invasion, and in vivo xenograft growth. Has-miR-485-5p was confirmed to be bound by BLACAT1 and its expression in HCC cells inversely regulated by BLACAT1. Then, has-miR-485-5p downregulation reversed the inhibitory effects of BLACAT1 downregulation on HCC cancer cell in vitro functions.
Conclusion: BLACAT1 is aberrantly upregulated in HCC and its inhibition had tumor suppressing effects in human HCC, possibly through endogenously competing against has-miR-485-5p. The BLACAT1/ has-miR-485-5p regulatory axis may be a molecular target for future HCC therapy.
Sun Z, Wang H, Xu Y, Liu Y, Wang L, Zhou R J Gastrointest Oncol. 2024; 15(2):641-667.
PMID: 38756632 PMC: 11094489. DOI: 10.21037/jgo-23-956.
Yang S, Ruan X, Hu B, Tu J, Cai H Cell Tissue Res. 2023; 394(3):441-453.
PMID: 37851112 DOI: 10.1007/s00441-023-03834-x.
The RNA interactome in the Hallmarks of Cancer.
Gabryelska M, Conn S Wiley Interdiscip Rev RNA. 2023; 14(5):e1786.
PMID: 37042179 PMC: 10909452. DOI: 10.1002/wrna.1786.
Rau C, Kuo P, Lin H, Wu C, Wu Y, Chien P J Inflamm Res. 2022; 15:5491-5503.
PMID: 36172547 PMC: 9512539. DOI: 10.2147/JIR.S375881.
Peng Y, Xu J, Zeng C, Zhao X, Li L, Qi L Ann Transl Med. 2022; 10(10):549.
PMID: 35722392 PMC: 9201140. DOI: 10.21037/atm-22-1958.